Archives: Speakers

Thomas Mann is an Associate Director at Alfa with over a decade of experience delivering large and complex transformation programmes for banks, captives, and automotive finance providers across the UK and Europe. He works with customers to implement Alfa Systems and support business transformation initiatives, helping automotive finance organisations modernise their lending and leasing operations, improve efficiency, and drive business growth.

Enrico Ugoletti is a senior executive at Finomnia with extensive experience in digital innovation, financial services, and business transformation. Having worked across international consulting and banking environments, he now supports banks and leasing providers throughout Europe in leveraging AI and advanced technologies to drive growth, efficiency, and customer value.

Tine Rosenberg is Head Nurse at the Cardiology Trial Unit, Rigshospitalet. She has been working in clinical research since 2010 and has extensive experience in the planning, coordination, and management of clinical trials and investigator-initiated studies all the years with a strong focus on research quality, patient safety, and evidence-based practice.

Michelle Novak has more than 25 years of experience in the healthcare industry, having held positions within both global and emerging pharmaceutical and medical device organizations. Over the past eight years, she has specialized in supporting sponsors with their clinical supply needs, developing strategic solutions that enhance clinical trial execution and operational success.

Michelle currently serves as Regional Director, Business Development at Inceptua, a global clinical supply company, where she partners with sponsors to navigate the complexities of clinical supply chain management across all phases of development. Throughout her career in clinical supplies, she has supported global clinical trials across multiple countries, regions, and study phases, helping organizations optimize study execution through the effective use of pharmacy-based distribution models and local, regional, and centralized sourcing strategies.

François Camilleri rejoint Natixis Lease en 2002 pour développer les activités internationales de crédit-bail du groupe.

Il crée notamment les succursales de Madrid et de Milan et lance les activités de leasing en Algérie et au Maroc. En 2006, il prend en charge la direction du Développement, puis la direction Commerciale et devient en 2011 directeur général adjoint en charge de la filière Crédit-bail mobilier en France, Outre-Mer et International. En 2015, il pilote également le développement du Crédit-bail immobilier. En 2016, il devient directeur général délégué de Natixis Lease, devenue BPCE Lease et en mars 2025, il est nommé directeur général de BPCE Lease.

François Camilleri est aussi président de la commission du Crédit-bail, administrateur et membre du bureau de l’Association française des Sociétés Financières (ASF).

François Camilleri joined Natixis Lease in 2002 to develop the group’s international leasing activities.
He set up the branches in Madrid and Milan and launched leasing operations in Algeria and Morocco. In 2006, he took charge of the Development department, then the Sales department, and in 2011 became Deputy Chief Executive in charge of the equipment leasing division in France, the Overseas Territories and internationally. In 2015, he also led the development of real estate leasing. In 2016, he became Deputy Chief Executive of Natixis Lease, which then became BPCE Lease, and in March 2025, he was appointed Chief Executive of BPCE Lease.

François Camilleri is Chairman of the Finance Lease Committee, board member and member of the Executive Committee of the French Association of Financial Companies (ASF).

Stefan Günther is a Director at KPMG Germany specializing in transaction-related transformations and value creation initiatives. His expertise spans automotive finance, leasing, and captive finance, including the setup and transformation of captive finance and leasing institutions. He advises clients on operating model design, post-merger integration, and large-scale transformation programs. Stefan is particularly recognized for translating strategic ambitions into executable roadmaps that deliver sustainable business outcomes and long-term competitive advantage.

Alexander Mäsch is a Partner in Financial Services Consulting at KPMG Germany, where he advises captives, financial services and automotive companies on strategic and operational transformation and business growth. His expertise spans customer transformation, digital operating models, process optimization, and large-scale transition programs. He is particularly recognized for translating strategic ambitions into executable transformation roadmaps that deliver sustainable business outcomes and long-term competitive advantage.

Christopher Schlebusch brings over two decades of clinical research leadership, having directed global trial operations and high-performing project management teams across top-tier CROs. His core expertise spans multinational portfolio governance, scalable process optimisation, and the integration of advanced technologies, including AI-driven operational tools, to maximise efficiency and quality.

As Global Head of Project Management and Clinical Monitoring at Clarenta, he oversees international clinical delivery, steering operational integration, resource management and strategic partnerships. Christopher is committed to execution excellence and supporting sustainable business growth across the organisation’s expanding portfolio.

Walker Bradham is the Senior Director of Product Management & Design for Zelta, where he leads the strategy and evolution of a modern, cloud-based clinical data platform used by sponsors and CROs worldwide. With more than ten years of experience working on Zelta, he has been at the forefront of its transformation toward a more intelligent, scalable, and design-driven system for clinical trial execution.

His current focus is on applying AI in meaningful, responsible ways; accelerating study builds, improving data quality, and reducing operational burden without compromising compliance. Known for bridging technical innovation with real-world trial challenges, Walker brings a pragmatic perspective to how AI can be adopted today to create tangible value for clinical teams.